U87MG Cells

The U87MG cell line, established from a human glioblastoma, is one of the most widely utilized cellular models in neurobiological and cancer research. Originating from a malignant tumor of the central nervous system, these cells exhibit many of the hallmark features of glioblastoma multiforme (GBM), including rapid proliferation, high invasiveness, and significant genetic and phenotypic heterogeneity. This makes the U87MG cell line, also referred to as U87 cells, an invaluable tool for exploring the molecular and cellular mechanisms underlying brain tumors, as well as for testing potential therapeutic strategies. In neuroscience and immuno-oncology research, U87MG cells serve as a model to elucidate the cell function and cytotoxicity mechanisms in glioblastoma, including the exploration of NK cell cytotoxicity. The expression of NKG2D ligands on U87 cells and the use of NKG2D antibodies in studies highlight the intricate dynamics between cancer cells and the immune system, particularly NK cells, in the tumor microenvironment. The stemness features of U87 glioblastoma cells, alongside their genetic and phenotypic attributes, are subjects of intense study, aiming to unravel the mechanisms that confer these cells a high degree of plasticity and resistance to conventional therapies. The U87 cell line's exact origin remains somewhat enigmatic, with genetic analyses revealing differences from the original tumor. In summary, the U87 cell line remains a fundamental tool in glioblastoma research, facilitating a deeper understanding of the disease's biology and the quest for more effective treatments. Brain cancer cell lines, Brain, Glioblastoma, Growth Conditions: Adherent, Biosafety level: BSL 1